PUBLISHER: Grand View Research | PRODUCT CODE: 1529858
PUBLISHER: Grand View Research | PRODUCT CODE: 1529858
The global endoscopic vessel harvesting system market size is expected to reach USD 195.1 billion by 2030, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 3.5% from 2023 to 2030. The increasing prevalence of cardiovascular diseases globally, such as peripheral artery disease & coronary artery disease, and growing preference for minimally invasive harvesting attributed to its benefits over conventional methods, and the rising geriatric population. According to World Health Organization study published in May 2024, in Europe, CVDs are the leading cause of disability and premature death. Statistics indicate that CVDs account for over 42.0% of all deaths annually in Europe. That is approximately 10,000 deaths every day attributed to cardiovascular diseases.
Moreover, the growing incidents of heart disorders including atrial fibrillation, and angina pectoris, are a leading cause of morbidity and mortality globally. For instance, according to the National Library of Medicine, the prevalence of angina pectoris worldwide ranged from approximately 2% to 7% in 2024.
In addition, the increasing demand for coronary artery bypass graft (CABG) surgeries. CABG is a procedure commonly used to address coronary artery disease (CAD). With factors such as aging populations, sedentary lifestyles, and rising rates of diabetes and obesity contributing to the growing prevalence of CAD, there has been a corresponding rise in the number of CABG procedures. This uptick in CABG surgeries underscores the necessity for efficient and minimally invasive harvesting techniques like EVH.